{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:25:55Z","timestamp":1774513555069,"version":"3.50.1"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Mental disorders are heterogeneous and psychiatric comorbidities are common. Previous studies have suggested a link between inflammation and mental disorders. This link can manifest as increased levels of proinflammatory mediators in circulation and as signs of neuroinflammation. Furthermore, there is strong evidence that individuals suffering from psychiatric disorders have increased risk of developing metabolic comorbidities. Our group has previously shown that, in a cohort of low-functioning individuals with serious mental disorders, there is increased expression of genes associated with the NLRP3 inflammasome, a known sensor of metabolic perturbations, as well as increased levels of IL-1-family cytokines. In the current study, we set out to explore the interplay between disease-specific changes in lipid metabolism and known markers of inflammation. To this end, we performed mass spectrometry-based lipidomic analysis of plasma samples from low-functioning individuals with serious mental disorders (<jats:italic>n<\/jats:italic> = 39) and matched healthy controls (<jats:italic>n<\/jats:italic> = 39). By identifying non-spurious immune-lipid associations, we derived a partial correlation network of inflammatory markers and molecular lipids. We identified levels of lipids as being altered between individuals with serious mental disorders and controls, showing associations between lipids and inflammatory mediators, e.g., osteopontin and IL-1 receptor antagonist. These results indicate that, in low-functioning individuals with serious mental disorders, changes in specific lipids associate with immune mediators that are known to affect neuroinflammatory diseases.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.778325","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T07:08:59Z","timestamp":1638342539000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Potential Transdiagnostic Lipid Mediators of Inflammatory Activity in Individuals With Serious Mental Illness"],"prefix":"10.3389","volume":"12","author":[{"given":"Ulrika","family":"Hyl\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidan","family":"McGlinchey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matej","family":"Ore\u0161i\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Bejerot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats B.","family":"Humble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"S\u00e4rndahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuulia","family":"Hy\u00f6tyl\u00e4inen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S2215-0366(15)00505-2","article-title":"Thornicroft G, Atun R. Estimating the true global burden of mental illness","volume":"3","author":"Vigo","year":"2016","journal-title":"Lancet Psychiatry."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0140-6736(19)32316-5","article-title":"A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study","volume":"394","author":"Plana-Ripoll","year":"2019","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"Association","year":"2013"},{"key":"B4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jamapsychiatry.2018.3658","article-title":"Exploring comorbidity within mental disorders among a Danish national population","volume":"76","author":"Plana-Ripoll","year":"2019","journal-title":"JAMA Psychiatry."},{"key":"B5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/wps.20512","article-title":"Why the clinical utility of diagnostic categories in psychiatry is intrinsically limited and how we can use new approaches to complement them","volume":"17","author":"Maj","year":"2018","journal-title":"World Psychiatry."},{"key":"B6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/wps.20680","article-title":"Transdiagnostic psychiatry goes above and beyond classification","volume":"18","author":"Mansell","year":"2019","journal-title":"World Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/npp.2016.211","article-title":"Towards an immunophenotype of schizophrenia: progress, potential mechanisms, and future directions","volume":"42","author":"Miller","year":"2017","journal-title":"Neuropsychopharmacology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/npp.2016.158","article-title":"The role of the immune system in autism spectrum disorder","volume":"42","author":"Meltzer","year":"2017","journal-title":"Neuropsychopharmacology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1001\/jamapsychiatry.2017.1567","article-title":"Inflammation in the neurocircuitry of obsessive-compulsive disorder","volume":"74","author":"Attwells","year":"2017","journal-title":"JAMA Psychiatry."},{"key":"B11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41398-019-0570-y","article-title":"Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses","volume":"9","author":"Yuan","year":"2019","journal-title":"Transl Psychiatry."},{"key":"B12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.schres.2017.11.023","article-title":"Cytokines dysregulation in schizophrenia: a systematic review of psychoneuroimmune relationship","volume":"197","author":"Rodrigues-Amorim","year":"2017","journal-title":"Schizophr Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/mp.2014.59","article-title":"Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis","volume":"20","author":"Masi","year":"2015","journal-title":"Mol Psychiatry."},{"key":"B14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S2215-0366(17)30101-3","article-title":"Brain microglia in psychiatric disorders","volume":"4","author":"Mondelli","year":"2017","journal-title":"Lancet Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/10408398.2018.1529653","article-title":"Lipids as biomarkers of brain disorders","volume":"60","author":"Hussain","year":"2020","journal-title":"Crit Rev Food Sci Nutr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fpsyt.2018.00459","article-title":"Lipidomics in major depressive disorder","volume":"9","author":"Walther","year":"2018","journal-title":"Front Psychiatry."},{"key":"B17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fnins.2016.00488","article-title":"From molecules to the clinic: linking schizophrenia and metabolic syndrome through sphingolipids metabolism","volume":"10","author":"Castillo","year":"2016","journal-title":"Front Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/gm233","article-title":"Metabolome in schizophrenia and other psychotic disorders: a general population-based study","volume":"3","author":"Ore\u0161i\u010d","year":"2011","journal-title":"Genome Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.psychres.2018.12.008","article-title":"Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia","volume":"272","author":"Wang","year":"2019","journal-title":"Psychiatry Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/imr.12891","article-title":"Lipids, inflammasomes, metabolism, and disease","volume":"297","author":"Anand","year":"2020","journal-title":"Immunol Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3390\/cells9081808","article-title":"The NLRP3 Inflammasome: metabolic regulation and contribution to inflammaging","volume":"9","author":"Meyers","year":"2020","journal-title":"Cells."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.4049\/jimmunol.1300298","article-title":"Inflammasome-mediated secretion of IL-1\u03b2 in human monocytes through TLR2 activation; modulation by dietary fatty acids","volume":"191","author":"Snodgrass","year":"2013","journal-title":"J Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1161\/ATVBAHA.117.310581","article-title":"Saturated fatty acids undergo intracellular crystallization and activate the NLRP3 inflammasome in macrophages","volume":"38","author":"Karasawa","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"577119","DOI":"10.1016\/j.jneuroim.2019.577119","article-title":"Increased inflammasome activity in markedly ill psychiatric patients: an explorative study","volume":"339","author":"Hyl\u00e9n","year":"2020","journal-title":"J Neuroimmunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1016\/j.celrep.2016.08.036","article-title":"Dynamic response genes in CD4+ T cells reveal a network of interactive proteins that classifies disease activity in multiple sclerosis","volume":"16","author":"Hellberg","year":"2016","journal-title":"Cell Rep."},{"key":"B28","first-page":"22","article-title":"The mini-international neuropsychiatric interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry."},{"key":"B29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/1073191114565878","article-title":"Diagnosis and characterization of DSM-5 nonsuicidal self-injury disorder using the clinician-administered nonsuicidal self-injury disorder index","volume":"22","author":"Gratz","year":"2015","journal-title":"Assessment."},{"key":"B30","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"B31","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1192\/bjp.166.5.654","article-title":"A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF)","volume":"166","author":"Jones","year":"1995","journal-title":"Br J Psychiatry."},{"key":"B32","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2471\/BLT.09.067231","article-title":"Developing the world health organization disability assessment schedule 2.0","volume":"88","author":"Ustun","year":"2010","journal-title":"Bull World Health Organ"},{"key":"B33","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/1073191113486183","article-title":"The psychometric properties of the personality inventory for DSM-5 in an APA DSM-5 field trial sample","volume":"20","author":"Quilty","year":"2013","journal-title":"Assessment."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1600-0447.1995.tb09801.x","article-title":"Yale-brown obsessive compulsive scale and us national institute of mental health global obsessive compulsive scale in Turkish: reliability and validity","volume":"91","author":"Tek","year":"1995","journal-title":"Acta Psychiatr Scand."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-244X-13-4","article-title":"Measuring engagement in deliberate self-harm behaviours: psychometric evaluation of six scales","volume":"13","author":"Latimer","year":"2013","journal-title":"BMC Psychiatry."},{"key":"B38","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem."},{"key":"B39","article-title":"Prenatal Exposure To Environmental Chemicals Modulates Serum Phospholipids In Newborn Infants, Increasing Later Risk Of Type 1 Diabetes","author":"McGlinchey","year":"2019","journal-title":"bioRxiv"},{"key":"B40","year":""},{"key":"B41","author":"Wei","year":"2017","journal-title":"Package \u201ccorrplot\u201d: Visualization of a Correlation Matrix"},{"key":"B42","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/rssc.12166","article-title":"The networked partial correlation and its application to the analysis of genetic interactions","volume":"66","author":"Roverato","year":"2017","journal-title":"J R Stat Soc Ser C Appl Stat."},{"key":"B43","author":"Hansen","year":"2021","journal-title":"Rgraphviz: Provides Plotting Capabilities For R Graph Objects"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.c01","article-title":"Beanplot: a boxplot alternative for visual comparison of distributions","volume":"28","author":"Kampstra","year":"2008","journal-title":"J Stat Softw."},{"key":"B45","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s13238-017-0423-5","article-title":"Structural and functional roles of ether lipids","volume":"9","author":"Dean","year":"2018","journal-title":"Protein Cell."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/1873-3468.12788","article-title":"From peroxisomal disorders to common neurodegenerative diseases-the role of ether phospholipids in the nervous system","volume":"591","author":"Dorninger","year":"2017","journal-title":"FEBS Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e906","DOI":"10.1038\/tp.2016.142","article-title":"Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations","volume":"6","author":"Tessier","year":"2016","journal-title":"Transl Psychiatry."},{"key":"B48","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.schres.2014.11.032","article-title":"Dysfunctional plasmalogen dynamics in the plasma and platelets of patients with schizophrenia","volume":"161","author":"Wood","year":"2015","journal-title":"Schizophr Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/schbul\/sby125","article-title":"Oxidative stress and inflammation in first-episode psychosis: a systematic review and meta-analysis","volume":"45","author":"Fraguas","year":"2019","journal-title":"Schizophr Bull."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1007\/s12035-019-01742-2","article-title":"Oxidative stress in autism spectrum disorder","volume":"57","author":"Bj\u00f8rklund","year":"2020","journal-title":"Mol Neurobiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.psyneuen.2010.03.010","article-title":"Depression and oxidative damage to lipids","volume":"35","author":"Yager","year":"2010","journal-title":"Psychoneuroendocrinology."},{"key":"B52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1189\/jlb.3VMA1215-579RR","article-title":"Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages","volume":"101","author":"Yeon","year":"2017","journal-title":"J Leukoc Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol Psychiatry."},{"key":"B54","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/acps.12783","article-title":"Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study","volume":"136","author":"M\u00f8rch","year":"2017","journal-title":"Acta Psychiatr Scand."},{"key":"B55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.schres.2017.03.031","article-title":"Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: a systematic review and meta-analysis","volume":"190","author":"Misiak","year":"2017","journal-title":"Schizophr Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1192\/bjp.bp.117.200907","article-title":"Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis","volume":"211","author":"Pillinger","year":"2017","journal-title":"Br J Psychiatry."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1007\/s00125-013-2981-2","article-title":"Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids","volume":"56","author":"Ore\u0161i\u010d","year":"2013","journal-title":"Diabetologia."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e951","DOI":"10.1038\/tp.2016.222","article-title":"Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis","volume":"6","author":"Suvitaival","year":"2016","journal-title":"Transl Psychiatry."},{"key":"B59","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/acps.12388","article-title":"Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia","volume":"132","author":"Solberg","year":"2015","journal-title":"Acta Psychiatr Scand."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1879437","DOI":"10.1155\/2017\/1879437","article-title":"The effect of osteopontin on microglia","volume":"2017","author":"Yu","year":"2017","journal-title":"Biomed Res Int."},{"key":"B61","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3389\/fpsyt.2019.00996","article-title":"Elevated osteopontin and interferon gamma serum levels and increased neutrophil-to-lymphocyte ratio are associated with the severity of symptoms in schizophrenia","volume":"10","author":"Kov\u00e1cs","year":"2019","journal-title":"Front Psychiatry."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e1208","DOI":"10.1038\/cddis.2014.174","article-title":"Osteopontin deficiency aggravates hepatic injury induced by ischemia-reperfusion in mice","volume":"5","author":"Patouraux","year":"2014","journal-title":"Cell Death Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.4103\/1673-5374.300328","article-title":"The Yin-Yang of osteopontin in nervous system diseases: damage versus repair","volume":"16","author":"Cappellano","year":"2021","journal-title":"Neural Regen Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11017-015-9321-0","article-title":"Psychiatric comorbidity: fact or artifact?","volume":"36","author":"van Loo","year":"2015","journal-title":"Theor Med Bioeth."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00787-020-01478-8","article-title":"Co-occurring obsessive-compulsive disorder and autism spectrum disorder in young people: prevalence, clinical characteristics and outcomes","volume":"29","author":"Martin","year":"2020","journal-title":"Eur Child Adolesc Psychiatry."},{"key":"B66","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11920-019-1051-y","article-title":"Obsessive-compulsive symptoms in schizophrenia: an up-to-date review of literature","volume":"21","author":"Tezenas du Montcel","year":"2019","journal-title":"Curr Psychiatry Rep"},{"key":"B67","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/acps.12644","article-title":"Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review","volume":"135","author":"Jobski","year":"2017","journal-title":"Acta Psychiatr Scand."},{"key":"B68","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12888-014-0317-5","article-title":"A typical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis","volume":"14","author":"Veale","year":"2014","journal-title":"BMC Psychiatry."},{"key":"B69","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/070674371405901103","article-title":"Treating nonsuicidal self-injury: a systematic review of psychological and pharmacological interventions","volume":"59","author":"Turner","year":"2014","journal-title":"Can J Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.778325\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T07:09:05Z","timestamp":1638342545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.778325\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":69,"alternative-id":["10.3389\/fpsyt.2021.778325"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.778325","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]},"article-number":"778325"}}